Compare KNOP & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KNOP | SOPH |
|---|---|---|
| Founded | 2013 | 2011 |
| Country | United Kingdom | Switzerland |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 346.6M | 330.4M |
| IPO Year | 2013 | 2021 |
| Metric | KNOP | SOPH |
|---|---|---|
| Price | $10.74 | $4.69 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | ★ 141.2K | 101.5K |
| Earning Date | 12-04-2025 | 11-04-2025 |
| Dividend Yield | ★ 0.98% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 1.17 | N/A |
| Revenue | ★ $352,712,000.00 | $73,297,000.00 |
| Revenue This Year | $13.56 | $18.32 |
| Revenue Next Year | $2.42 | $15.61 |
| P/E Ratio | $9.08 | ★ N/A |
| Revenue Growth | ★ 17.65 | 13.66 |
| 52 Week Low | $5.28 | $2.58 |
| 52 Week High | $10.99 | $5.30 |
| Indicator | KNOP | SOPH |
|---|---|---|
| Relative Strength Index (RSI) | 66.95 | 52.09 |
| Support Level | $10.41 | $4.54 |
| Resistance Level | $10.85 | $4.84 |
| Average True Range (ATR) | 0.22 | 0.30 |
| MACD | 0.04 | -0.02 |
| Stochastic Oscillator | 79.57 | 39.25 |
KNOT Offshore Partners LP owns, operates, and shuttles tankers under long-term charters in the North Sea and Brazil. The company provides crude oil loading, transportation, and storage services under time charters and bareboat charters. The Partnership is formed for acquiring ownership interests in over four shuttle tankers owned by Knutsen NYK Offshore Tankers AS (KNOT). It operates through the shuttle tanker market segment.
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.